Statements (50)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:disease
hematologic disorder |
gptkbp:abbreviation |
gptkb:MDS
|
gptkbp:affects |
blood
bone marrow |
gptkbp:can_be_secondary_to |
radiation therapy
chemotherapy congenital syndromes benzene exposure |
gptkbp:can_progress_to |
gptkb:acute_myeloid_leukemia
|
gptkbp:cause |
cytopenia
ineffective hematopoiesis |
gptkbp:diagnosedBy |
blood test
bone marrow biopsy |
gptkbp:eponymOf |
preleukemia
|
gptkbp:firstDescribed |
1976
|
gptkbp:has_cell_type |
dysplastic erythrocytes
dysplastic granulocytes dysplastic megakaryocytes |
gptkbp:has_genetic_abnormality |
gptkb:TP53_mutation
chromosome 5q deletion chromosome 7q deletion trisomy 8 |
https://www.w3.org/2000/01/rdf-schema#label |
Myelodysplastic syndrome
|
gptkbp:ICD-10_code |
D46
|
gptkbp:marking |
blasts in bone marrow
dysplasia in at least one cell line ring sideroblasts |
gptkbp:prognosis |
variable
|
gptkbp:prognostic_scoring_system |
IPSS
IPSS-R |
gptkbp:riskFactor |
radiation exposure
genetic predisposition older age previous chemotherapy |
gptkbp:subspecies |
5q- syndrome
refractory anemia refractory anemia with excess blasts refractory cytopenia with multilineage dysplasia |
gptkbp:symptom |
gptkb:anemia
fatigue infections easy bruising |
gptkbp:treatment |
supportive care
chemotherapy blood transfusion growth factors stem cell transplantation |
gptkbp:bfsParent |
gptkb:MDS
|
gptkbp:bfsLayer |
6
|